{'fraction_non_alphanumeric': 0.03430079155672823, 'fraction_numerical': 0.002638522427440633, 'mean_word_length': 5.440677966101695, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
MS and bone marrow transplant

In the article “Autologous hematopoietic stem cell transplantation in multiple sclerosis: A meta-analysis,” Sormani et al.1 found studies that had already been published about autologous hematopoietic stem cell transplantation (aHSCT) for treatment of multiple sclerosis (MS) (see the next page for an introduction to aHSCT in the treatment of MS).